Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001239946 | SCV001412855 | likely benign | Nemaline myopathy 2 | 2023-11-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004034631 | SCV004979040 | uncertain significance | Inborn genetic diseases | 2024-01-03 | criteria provided, single submitter | clinical testing | The c.17028C>G (p.H5676Q) alteration is located in exon 123 (coding exon 121) of the NEB gene. This alteration results from a C to G substitution at nucleotide position 17028, causing the histidine (H) at amino acid position 5676 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001239946 | SCV002084044 | uncertain significance | Nemaline myopathy 2 | 2020-06-09 | no assertion criteria provided | clinical testing |